A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
- DOI
- 10.1093/oncolo/oyad158
- Published
- 2023-12-01
- Container
- Oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyad158,
title = {A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.},
author = {Nelson BE and Tsimberidou AM and Fu X and Fu S and Subbiah V and Sood AK and Rodon J and Karp DD and Blumenschein G and Kopetz S and Pant S and Piha-Paul SA.},
year = {2023},
journal = {Oncologist},
doi = {10.1093/oncolo/oyad158},
url = {https://doi.org/10.1093/oncolo/oyad158}
}RIS
TY - JOUR TI - A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors. AU - Nelson BE AU - Tsimberidou AM AU - Fu X AU - Fu S AU - Subbiah V AU - Sood AK AU - Rodon J AU - Karp DD AU - Blumenschein G AU - Kopetz S AU - Pant S AU - Piha-Paul SA. PY - 2023 JO - Oncologist DO - 10.1093/oncolo/oyad158 UR - https://doi.org/10.1093/oncolo/oyad158 ER -
APA
BE, N., AM, T., X, F., S, F., V, S., AK, S., J, R., DD, K., G, B., S, K., S, P., & SA., P. (2023). A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.. Oncologist. https://doi.org/10.1093/oncolo/oyad158
Source records
- europe-pmc · retrieved 2026-09-27T12:40:20.951Z